EQUITY RESEARCH MEMO

Ranfac Corp

Generated 5/11/2026

Executive Summary

Conviction (model self-assessment)55/100

Ranfac Corp is a privately held, high-mix medical device contract manufacturer specializing in custom Class I and II devices. Founded in 1970 and based in Avon, Massachusetts, the company provides integrated design, development, and manufacturing services (CDMO/CMO) from raw materials through sterile packaging. Serving orthobiologics, surgery, radiology, and hematology applications, Ranfac differentiates itself as a single-source partner for complex, low-volume production. While the company lacks prominent public visibility, its long operational history and niche focus suggest stable revenue streams. Growth prospects hinge on expanding capacity or securing new CDMO agreements. Ranfac's private status limits financial disclosure, but its established market presence and breadth of capabilities provide a moderate conviction for continued relevance in the medical device outsourcing space.

Upcoming Catalysts (preview)

  • TBDNew CDMO partnership with a medtech OEM50% success
  • TBDFacility expansion or capacity upgrade announcement40% success
  • TBDEntry into higher-growth segment (e.g., single-use surgical instruments)30% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)